Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Regorafenib”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT06283303
What this trial is testing

A Clinical Study of T3011 in Combination With Toripalimab and Regorafenib in Patients With Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
China Medical University, China 8
Testing effectiveness (Phase 2)Study completedNCT04051606
What this trial is testing

Regorafenib in Bevacizumab Refractory Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma
Case Comprehensive Cancer Center 14
Testing effectiveness (Phase 2)UnknownNCT05877001
What this trial is testing

The Safety and Efficacy of HAIC+Tislelizumab+Regorafenib in Patients With Colorectal Liver Metastases

Who this might be right for
Colorectal Liver Metastases
Peking University Cancer Hospital & Institute 20
Not applicableUnknownNCT05818267
What this trial is testing

Efficacy and Safety of Regorafenib Maintenance Therapy in Patients With Metastatic Colorectal Cancer (mCRC)

Who this might be right for
Colorectal Cancer
Wei Zhang 30
Testing effectiveness (Phase 2)Study completedNCT04170556
What this trial is testing

Regorafenib Followed by Nivolumab in Patients With Hepatocellular Carcinoma (GOING)

Who this might be right for
Hepatocellular Carcinoma
Fundacion Clinic per a la Recerca Biomédica 69
Large-scale testing (Phase 3)Looking for participantsNCT05462613
What this trial is testing

Regorafenib With Low-dose Chemotherapies and Aspirin Followed by Standard Chemotherapies in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Centre Hospitalier Universitaire de Besancon 446
Large-scale testing (Phase 3)Study completedNCT01584830
What this trial is testing

Asian Subjects With Metastatic Colorectal Cancer Treated With Regorafenib or Placebo After Failure of Standard Therapy

Who this might be right for
Colorectal Neoplasms
Bayer 204
Not applicableStudy completedNCT01265979
What this trial is testing

WB-DWI for Early Prediction of Therapy Response in Patients With Advanced Metastatic GIST Treated With Regorafenib

Who this might be right for
Gastrointestinal Stromal Tumors
Universitaire Ziekenhuizen KU Leuven 5
Testing effectiveness (Phase 2)UnknownNCT03992456
What this trial is testing

Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer

Who this might be right for
Metastatic Colon AdenocarcinomaMetastatic Colorectal CarcinomaMetastatic Rectal Adenocarcinoma+27 more
Academic and Community Cancer Research United 12
Testing effectiveness (Phase 2)Ended earlyNCT02425683
What this trial is testing

Study of Colorectal Cancer Patients (Stage IIIC) With Either Regorafenib or Standard of Care (No Treatment) After Adjuvant FOLFOX

Who this might be right for
Colorectal NeoplasmsAdenocarcinoma of the ColonAdenocarcinoma of the Rectum
US Oncology Research 24
Testing effectiveness (Phase 2)Study completedNCT02406170
What this trial is testing

Regorafenib in Combination With Paclitaxel in Advanced Oesophagogastric Carcinoma

Who this might be right for
Esophageal NeoplasmsStomach NeoplasmsNeoplasm Metastasis
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 47
Testing effectiveness (Phase 2)UnknownNCT03475953
What this trial is testing

A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors

Who this might be right for
Colorectal Cancer Not MSI-H or MMR-deficientGISTOesophageal or Gastric Carcinoma+12 more
Institut Bergonié 747
Testing effectiveness (Phase 2)Ended earlyNCT04476329
What this trial is testing

Optimization for Regorafenib in HCC

Who this might be right for
Hepatocellular Carcinoma
SC Liver Research Consortium, LLC 7
Early research (Phase 1)Study completedNCT03042689
What this trial is testing

Study of Regorafenib in Patients With Advanced Myeloid Malignancies

Who this might be right for
Acute Myeloid Leukemia
Massachusetts General Hospital 16
Testing effectiveness (Phase 2)Study completedNCT06071052
What this trial is testing

TACE Plus HAIC Combined With Regorafenib for Liver Metastasis of Colorectal Cancer Refractory to Standard Treatment Regimens

Who this might be right for
Liver Metastasis Colon Cancer
First Affiliated Hospital, Sun Yat-Sen University 21
Testing effectiveness (Phase 2)Study completedNCT02098538
What this trial is testing

Regorafenib in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma

Who this might be right for
Adenoid Cystic Carcinoma
Memorial Sloan Kettering Cancer Center 38
Testing effectiveness (Phase 2)Ended earlyNCT02587650
What this trial is testing

Capmatinib, Ceritinib, Regorafenib, or Entrectinib in Treating Patients With BRAF/NRAS Wild-Type Stage III-IV Melanoma

Who this might be right for
ALK Fusion Protein ExpressionBRAF wt AlleleInvasive Skin Melanoma+12 more
University of California, San Francisco 1
Testing effectiveness (Phase 2)Study completedNCT01900743
What this trial is testing

Phase II Study of Regorafenib in Metastatic Soft Tissue Sarcoma

Who this might be right for
Sarcoma
Centre Oscar Lambret 219
Testing effectiveness (Phase 2)UnknownNCT02501551
What this trial is testing

Regorafenib, C-kit Mutated Malignant Melanoma, 2nd Line Therapy

Who this might be right for
Melanoma
Yonsei University 36
Early research (Phase 1)Study completedNCT01096030
What this trial is testing

Phase I Study of BAY73-4506 in Chinese Patients With Advanced, Refractory Solid Tumors

Who this might be right for
Neoplasms
Bayer 33
Next Page